Skip to content

Reduction of Sperm DNA Fragmentation by Oral Ginger

Reduction of Sperm DNA Fragmentation by Oral Ginger (Zingiberofficinale) Extract Treatment

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02032251
Enrollment
71
Registered
2014-01-09
Start date
2009-12-31
Completion date
2010-11-30
Last updated
2014-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

Sperm DNA damage ejaculated spermatozoa Ginger Herbal Drug Herbal medicine

Brief summary

This study is a randomized, double blind, controlled clinical trials assess the efficacy of the ginger oral treatment on sperm DNA fragmentation, sperm parameters and male hormones.

Detailed description

Sperm DNA fragmentation is known to affect male fertility. Previous findings have suggested the implication of oxidative stress in the etiology of this pathological condition. The present study was designed to find out DNA fragmentation in ejaculated spermatozoa can be reduced by oral treatment with Ginger extract. 71 men with unexplained or Idiopathic infertility were randomized between a Ginger treatment (500 milligram daily for 3months) group and a placebo group. Sperm DNA fragmentation was evaluated by Terminal deoxyribonucleotidyltransferase-mediated dUTP nick-end labeling assay (TUNEL) before and after treatment. No differences in basic sperm parameters were found between the Ginger treatment and the placebo group before or after treatment. However, the percentage of DNA-fragmented spermatozoa was markedly reduced (P\< .005) in the Ginger treatment group after the treatment as compared with the pretreatment values). No difference in the pretreatment and post treatment incidence of sperm DNA fragmentation was observed in the placebo group. These data show that sperm DNA damage can be efficiently treated with oral Ginger extract administered during a relatively short time period.

Interventions

DRUGoral administration of ginger

Oral administration of ginger in patients with infertility.

DRUGPlacebo

Sponsors

Royan Institute
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Age
20 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* men with idiopathic infertility or unexplained

Exclusion criteria

* history of varicocele, genitourinary inflammation or infection * history of cigarette smoking.

Design outcomes

Primary

MeasureTime frameDescription
sperm DNA fragmentation3 monthsEvaluation the percent of the reduction of sperm DNA fragmentation 3 months after ginger administration.

Secondary

MeasureTime frameDescription
male hormones3monthsEvaluation the effect of ginger on male hormones 3 months after oral administration.
sperm count3 monthsEvaluation the ginger on sperm count 3 months after oral administration.
sperm motility3 monthsEvaluation the effect of ginger on sperm motility 3 months after oral administration.

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026